Yesterday
The plan to save Australian lives with nationwide DNA screening
An ambitious vision to introduce mass genetic testing to the entire Australian adult population is being hailed as a solution to the country’s healthcare crisis. But can the health system cope?
- Michael Smith
September
Telix on $1b spending spree to build US radiopharmacy network
The biotech is investing heavily in global networks that will enable it to control the supply and distribution of nuclear medicines used to treat cancer.
- Michael Smith
July
The cheap vegetable that could save your life
According to a new study, eating carrots increases carotenoids in your skin. These phytonutrients lead to a lower risk of chronic disease and a stronger immune function.
- Jack Rear
June
Why people with cancer don’t get the full benefit of clinical trials
Australian researchers say regulators should mandate the requirement to share data.
- Jill Margo
Telix pulls $300m Nasdaq IPO as investors demand deep discount
The cancer treatment hopeful had announced plans to list in New York only last week as it searched for more capital. On Friday, it withdrew from the initial public offering.
- Kylar Loussikian
- Exclusive
- Healthcare
GenesisCare’s valuation shrinks to less than $500m after bankruptcy
Once a global cancer services giant, the company’s new owners are buying back shares from local backers for just $0.000186 as the business is restructured.
- Carrie LaFrenz
Immutep raises $100m and signs with Merck on ‘blockbuster’ drug
Shares in the oncology therapy hopeful have risen some 45 per cent in the last 12 months as the company nears the commercialisation of its drug, Efti.
- Kylar Loussikian
Biotech Immutep seeks $102 million, taps three brokers
The offer price reflects a 15.6 per cent discount to the last close.
- Sarah Thompson, Kanika Sood and Emma Rapaport
May
Former Liberal health minister appointed to cancer biotech’s board
Greg Hunt’s new company is developing a cure for a form of myeloma, a rare disease that begins in bone marrow.
- Aaron Patrick
How women can reduce the risk of breast cancer by 50pc
The science is sound but is not widely known that many women at increased risk of breast cancer can halve the risk with “anti-hormone” drugs.
- Jill Margo
The nine things every man needs to know about prostate cancer now
Experts at the cutting edge of new research into the causes and treatments answer the questions you might be afraid to ask.
- Catalina Stogdon
April
OpenAI’s model all but matches doctors in assessing eye problems
Ophthalmology has been a big focus of efforts to put AI to clinical use and fix obstacles to take-up, such as the tendency of models to ‘hallucinate’ by creating fictitious data.
- Michael Peel
Volpara Health takeover set to sail through shareholder vote
South Korean suitor Lunit moved to acquire the breast cancer detection medtech last year, entering into a scheme of arrangement with the board in December.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Revolutionary app offers vital prostate cancer info
A new online web app put out by the Prostate Cancer Foundation of Australia aims to help those living, recovering and at risk of the disease.
- Sophia McCaughan
March
Multivitamins can help survival from bowel cancer
A study examining the dose-related influence of multivitamins on non-metastatic colorectal cancer is believed to be the first of its kind.
- Jill Margo
The five factors behind rising rates of cancer in under 40s
Global cases in the under 50s are also rising rapidly, increasing by 79 per cent between 1990 and 2019 according to recent research.
- David Cox
- Analysis
- Royal family
Princess Catherine and the power of a cancer diagnosis
This year began as an annus horribilis for the royal family, but compassion coupled with a respectful fear of cancer, changed the narrative.
- Jill Margo
- Analysis
- Royalty
What Princess Kate’s ‘preventative chemotherapy’ means
With metastatic cancer, chemotherapy is used to make people more comfortable. With earlier stages of cancer, like Princess Kate’s, it aims to increase the chances of cure.
- Updated
- Jill Margo
Research we’re watching: pancreatic cancer, dementia, Arctic ice
We look at recent research in: pancreatic cancer; three-dimensional processors; an ice-free Arctic; a dementia breakthrough; and a new cash crop for Australia.
- Alana Piper
February
How the risk of cancer changes with age
The type of cancers that affect us in old age tend to strike different organs and have very different underlying causes, compared with the ones that strike people in their youth.
- David Cox